Impact of the COVID‐19 national lockdown in the allergic rhinitis symptoms in patients treated with immunotherapy at two allergy referral centers in Bogotá, Colombia

BACKGROUND: Coronavirus disease‐19 (COVID‐19) “lockdowns” caused an abruptly restricted access to health care services such as immunotherapy for allergic rhinitis (AR) and led to higher exposure to indoor allergens. This study aimed to assess the impact of COVID‐19 lockdowns on AR symptoms reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez‐Herrera, Lucia C., Ordoñez‐Cerón, Sebastián, Moreno‐López, Sergio, Peñaranda, Daniel, García, Elizabeth, Peñaranda, Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Allergy, Rhinology, and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008185/
https://www.ncbi.nlm.nih.gov/pubmed/35434342
http://dx.doi.org/10.1002/lio2.738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008185/
https://www.ncbi.nlm.nih.gov/pubmed/35434342
http://dx.doi.org/10.1002/lio2.738

Ejemplares similares